Open an account

GE Healthcare Technologies

GEHC · NASDAQ

$70.23+$0.47 (+0.67%)TodayMarket closed ·
Prev close $69.76

About GEHC

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 54,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

Employees
54,000
Headquarters
Chicago, Illinois
Listed
Dec 15, 2022
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
gehealthcare.com

GEHC key statistics

Market cap
31.51B
Price-earnings ratio
16.00
Dividend yield
0.20%
Average volume
3.62M
Volume
2.26M
Open price
$70.25
High today
$71.02
Low today
$69.63
52 Week high
$89.77
52 Week low
$58.75

GE Healthcare Technologies (GEHC) at a glance

GE Healthcare Technologies (GEHC) last traded at $70.23, with a market cap of 31.51B, a price-to-earnings ratio of 16.00 and a dividend yield of 0.20%.

Today the stock has traded between $69.63 and $71.02. The current price is 0.9% above the day's low and 1.1% below its high.

Volume so far is 2.26M shares, below the average of 3.62M shares a day.

Over the past year GE Healthcare Technologies has ranged from $58.75 to $89.77, and now sits 37% of the way up that range.

GE Healthcare Technologies met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $1.13 per share against an estimate of $1.06.

The average analyst price target is $85.79, 22.2% above the current price, from 19 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

53%of 19 analyst ratings say Buy
  • Buy52.6%
  • Hold47.4%
  • Sell0.0%
Price target · 24 analystsAvg $85.79
Low
$71.71
Now
$70.23
High
$100.80

GEHC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 8.1% on average.

  1. Q3 FY24: reported $1.14 per share against an estimate of $1.07
  2. Q4 FY24: reported $1.45 per share against an estimate of $1.29
  3. Q1 FY25: reported $1.01 per share against an estimate of $0.9316
  4. Q2 FY25: reported $1.06 per share against an estimate of $0.936
  5. Q3 FY25: reported $1.07 per share against an estimate of $1.07
  6. Q4 FY25: reported $1.44 per share against an estimate of $1.43
  7. Q1 FY26: reported $0.99 per share against an estimate of $1.07
  8. Q2 FY26: reported $1.13 per share against an estimate of $1.06

GEHC news

  • Press releaseBusiness Wire

    GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging

  • Press releaseBusiness Wire

    GE HealthCare expands general imaging ultrasound portfolio with LOGIQ Focus, elevating everyday ultrasound performance

  • Press releaseBusiness Wire

    Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow

  • Press releaseBusiness Wire

    GE HealthCare's MINItrace™ Magni achieves CE Mark; Copper-64 expands PETtrace™ Solid Target Platform beyond Gallium-68

  • Press releaseBusiness Wire

    GE HealthCare to announce third quarter 2026 results on October 28, 2026

  • Piero Cingari

    Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average

  • Press releaseGlobe Newswire

    Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Press releaseGlobe Newswire

    GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Similar companies

Companies in the same industry as GE Healthcare Technologies

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.